Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01237314 · ClinicalTrials.gov registry record
The Impact of Food on Blood Sugar in People With Type 2 Diabetes
A clinical trial of Type 2 Diabetes, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 46
- Enrollment target
- 1
- Study location
NCT01237314: Completed study of Type 2 Diabetes, sponsored by HealthPartners Institute.
NCT01237314 is a study of Type 2 Diabetes that has completed, run by HealthPartners Institute. The registered enrollment target is 46 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01237314, a study of Type 2 Diabetes, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will record the impact of food on blood glucose levels using continuous glucose monitoring (CGM). The investigators think the impact will improve as medication doses are adjusted. The investigators also think that the impact will differ depending on the type of medication taken.
Conditions Studied
Study Locations (1)
Minnesota
- International Diabetes Center - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01237314
The ClinicalTrials.gov registry entry for NCT01237314 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT01237314 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01237314 about?
NCT01237314 is a clinical study titled "The Impact of Food on Blood Sugar in People With Type 2 Diabetes". This study will record the impact of food on blood glucose levels using continuous glucose monitoring (CGM). The investigators think the impact will improve as medication doses are adjusted. The investigators also think that the impact will differ depending on the type of medication taken.
What is the current status of trial NCT01237314?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2010-11. Estimated completion is 2013-05.
What conditions does trial NCT01237314 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
Who is sponsoring clinical trial NCT01237314?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01237314 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
Mechanism of SGLT2 Inhibition in the Kidney
RECRUITING · Phase 4
-
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
RECRUITING · Early Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.